Clinical Safety , CorrelativeMarkers , andClinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma
暂无分享，去创建一个
C. Horak | M. Schell | G. Gibney | H. Inzunza | J. Weber | K. Fisher | R. Kudchadkar | L. Tetteh | R. Deconti | Bin Yu | I. Younos | Cabell Eysmans | A. Richards | M. Thebeau | Maria P. Czupryn | Alberto J Martinez